ROSTEN CONSULTING AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: TW
Trond Waldemar Rosten1966
Chairman of the board: TW
Trond Waldemar Rosten1966
Years since formation: 10 years; since Sep 27, 2014
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 300; 1 share class
Total number of shareholders: 2; persons

Financials

Total equity 2023: -7,575; NOK

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
TW Trond Waldemar Rosten 1966	Managing Director/CEO	50 % directly

Board

Name	Role	Shares
TW Trond Waldemar Rosten 1966	Chairman	50 % directly
CM Carolyn Mary Rosten 1979	Board Member	50 % directly

Others

Name	Role	Shares
A AS REGNSKAP & KONTOR	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
CM Carolyn Mary Rosten 1979	Board Member	50 % directly
TW Trond Waldemar Rosten 1966	Managing Director/CEO, Chairman	50 % directly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
CM Carolyn Mary Rosten 1979	Ordinary shares	150	50 %
TW Trond Waldemar Rosten 1966	Ordinary shares	150	50 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	0	0	0
Annual Total Result	0	0	0
Total assets	153	153	153
Total liabilities	7,729	7,728	7,728
Total equity	-7,575	-7,575	-7,575

P&L

Year	2023	2022	2021
Total operating income	0	0	0
Total operating costs	0	0	0
Operating result	0	0	0
Financial income/costs	0	0	0
Profit before tax	0	0	0
Total tax & extraordinary income/cost	0	0	0
Annual Total Result	0	0	0

Balance overview

Year	2023	2022	2021
Total fixed assets	0	0	0
Total current assets	153	153	153
Total assets	153	153	153
Short term debt	7,729	7,728	7,728
Long term debt	0	0	0
Total liabilities	7,729	7,728	7,728
Contributed capital	30,000	30,000	30,000
Retained earnings	-37,575	-37,575	-37,575
Total equity	-7,575	-7,575	-7,575
Total equity and liabilities	153	153	153

ROSTEN CONSULTING AS814 217 302